These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23844971)

  • 1. Risk factors and prognosis for clot formation on cardiac device leads.
    Rahbar AS; Azadani PN; Thatipelli S; Fleischmann KE; Nguyen N; Lee BK
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1294-300. PubMed ID: 23844971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobile thrombus on cardiac implantable electronic device leads of patients undergoing cardiac ablation: incidence, management, and outcomes.
    Sugrue A; DeSimone CV; Lenz CJ; Packer DL; Asirvatham SJ
    J Interv Card Electrophysiol; 2016 Aug; 46(2):115-20. PubMed ID: 26650730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biventricular defibrillator patients have higher complication rates after revision of recalled leads.
    Brumberg GE; Kaseer B; Shah H; Saba S; Jain S
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):665-71. PubMed ID: 22519559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade.
    Haghjoo M; Nikoo MH; Fazelifar AF; Alizadeh A; Emkanjoo Z; Sadr-Ameli MA
    Europace; 2007 May; 9(5):328-32. PubMed ID: 17369270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
    Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
    Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of lead revision for myocardial perforation after cardiac implantable electronic device placement.
    Huang XM; Fu HX; Zhong L; Osborn MJ; Asirvatham SJ; Sinak LJ; Cao J; Friedman PA; Cha YM
    J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1119-24. PubMed ID: 24863054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricuspid insufficiency after laser lead extraction.
    Rodriguez Y; Mesa J; Arguelles E; Carrillo RG
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):939-44. PubMed ID: 23713555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography.
    Downey BC; Juselius WE; Pandian NG; Estes NA; Link MS
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):679-83. PubMed ID: 21303389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus.
    Greenspon AJ; Rhim ES; Mark G; Desimone J; Ho RT
    Pacing Clin Electrophysiol; 2008 May; 31(5):548-53. PubMed ID: 18439167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study.
    Cantillon DJ; Ha K; Styperek R; Jumrussirikul P; Mirro M; Wong W; Wilkoff BL
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):855-62. PubMed ID: 23617316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients.
    Hercé B; Nazeyrollas P; Lesaffre F; Sandras R; Chabert JP; Martin A; Tassan-Mangina S; Bui HT; Metz D
    Europace; 2013 Jan; 15(1):66-70. PubMed ID: 23097224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects.
    Golzio PG; Fanelli AL; Vinci M; Pelissero E; Morello M; Grosso Marra W; Gaita F
    Europace; 2013 Jan; 15(1):89-100. PubMed ID: 22968846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser lead extraction: predictors of success and complications.
    Roux JF; Pagé P; Dubuc M; Thibault B; Guerra PG; Macle L; Roy D; Talajic M; Khairy P
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):214-20. PubMed ID: 17338718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological effects of implantable cardioverter-defibrillator leads under advisory.
    Heatherly SJ; Simmons T; Fitzgerald DM; Mitchell M
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):694-9. PubMed ID: 21410721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should all dysfunctional high-voltage leads be extracted? Results of a single-centre long-term registry.
    Bode F; Himmel F; Reppel M; Mortensen K; Schunkert H; Wiegand UK
    Europace; 2012 Dec; 14(12):1764-70. PubMed ID: 22753865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
    Borleffs CJ; van Rees JB; van Welsenes GH; van der Velde ET; van Erven L; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2010 Mar; 55(9):879-85. PubMed ID: 20185038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.